Biotech and pharma companies may be under pressure today after President Trump tweeted "I am working on a new system where there will be competition in the Drug industry. Pricing for the American people will come way down!"
The iShares Nasdaq Biotechnology Index Fund (IBB) is down 1% premarket on average volume as is the SPDR S&P Biotech ETF (XBI).